Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
Clinical trial NCT04014062 · COMPLETED
Trial details
- NCT number
- NCT04014062
- Sponsor
- Intas Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2018-05-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.